Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
James D Swift Insider Profile
4 Followers
James D Swift, CEO, Director at Pediatrix Medical Group, holds 75.94K shares in Pediatrix Medical Group (Ticker: MD).
James D Swift Pediatrix Medical Group (MD)CEO, Director
Pediatrix Medical Group (MD)
CEO, Director
Ranked #25,882 out of 98,743 Corporate Insiders
Profitable Transactions
2 out of 3 Profitable Transactions
Average Return
+22.50%
Average return per transaction
Time Frame
Compare to
Insider Roles
CEO, Director
Roles that James D Swift holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Nov 09, 2022 - Nov 09, 2023
Return:+38.20%
The most profitable trade made by James D Swift
James D Swift's Trading History
List of latest transactions for each holding click on a transaction to see James D Swift's performance on stock
You May Also Like
James D Swift insider profile FAQ
What is the percentage of profitable transactions made by James D Swift?
The percentage of profitable transactions made by James D Swift is 67%.
What is the average return per transaction made by James D Swift?
The average return per transaction made by James D Swift is 22.50%.
What stocks does James D Swift hold?
James D Swift holds: MD stocks.
What was James D Swift’s latest transaction?
James D Swift latest transaction was an Uninformative Sell of $136.68K.
What was James D Swift's most profitable transaction?
James D Swift’s most profitable transaction was an Informative Sell of MD stock on November 9, 2022. The return on the trade was 38.20%.
What is James D Swift's role in Pediatrix Medical Group?
James D Swift's role in Pediatrix Medical Group is CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.